AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23291317
Drug: Tomato juice
RxNorm normalized name: TOMATO JUICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tomato juice administered during and after exercise for over a 2-month period
Trial: 14568892
Drug: Cerivastatin (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cerivastatin (0.3 mg)
Trial: 31652452
Drug: PHOX2B rs28647582
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHOX2B rs28647582 T>C polymorphism (TC/CC genotypes)
Trial: 24974817
Drug: AREDS supplements
RxNorm normalized name: AR-9281
DrugBank: AR-9281 (DB06345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AREDS supplements (placebo, antioxidants (vitamin C, vitamin E, β-carotene), zinc, or a combination)
Trial: 24974817
Drug: AREDS supplements
RxNorm normalized name: AR-9281
DrugBank: AR-9281 (DB06345)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AREDS supplements
Trial: 17187005
Drug: Diane 35
RxNorm normalized name: Dianeal PD-2/2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diane 35 (cyproterone acetate 2 mg with ethinylestradiol 35 µg) for 6 months
Trial: 9086582
Drug: T3 (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T3 (0.2 microgram/kg bolus, 0.4 microgram/kg infusion over 6 hours)
Trial: 8412266
Drug: Postoperative cisplatin
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative cisplatin and vindesine chemotherapy
Trial: 30586843
Drug: Cashew nuts
RxNorm normalized name: Cashew nuts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cashew nuts (42 g/day)
Trial: 23301476
Drug: Auricular therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auricular therapy based on the pattern/syndrome differentiation
Trial: 23301476
Drug: Conventional auricular
RxNorm normalized name: fluocinolone
DrugBank: Fluocinolone (DB12553)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional auricular point sticking therapy
Trial: 14551489
Drug: Dexamethasone therapy
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone therapy for 4 days
Trial: 19713248
Drug: CAPOX (oxaliplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAPOX (oxaliplatin 65 mg/m2 i.v. days 1 and 8 and capecitabine 1000 mg/m2 orally b.i.d. days 1-14; q21d)
Trial: 19713248
Drug: CAPIRI (irinotecan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAPIRI (irinotecan 80 mg/m2 i.v. days 1 and 8 and capecitabine 1000 mg/m2 orally b.i.d. days 1-14; q21d)
Trial: 12670840
Drug: Sodium thiosulfate
RxNorm normalized name: Sodium Thiosulfate
DrugBank: Thiosulfuric acid (DB09499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium thiosulfate (STS) 0.125 mg
Trial: 12670840
Drug: Sodium thiosulfate
RxNorm normalized name: Sodium Thiosulfate
DrugBank: Thiosulfuric acid (DB09499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium thiosulfate (STS) 1.25 mg
Trial: 12670840
Drug: Sodium thiosulfate
RxNorm normalized name: Sodium Thiosulfate
DrugBank: Thiosulfuric acid (DB09499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium thiosulfate (STS) 12.5 mg
Trial: 12670840
Drug: Sodium thiosulfate
RxNorm normalized name: Sodium Thiosulfate
DrugBank: Thiosulfuric acid (DB09499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium thiosulfate (STS) 125 mg
Trial: 12670840
Drug: Sodium thiosulfate
RxNorm normalized name: Sodium Thiosulfate
DrugBank: Thiosulfuric acid (DB09499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium thiosulfate (STS) 1,250 mg
Trial: 11772961
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg oral baclofen
Trial: 30862500
Drug: Netarsudil ophthalmic
RxNorm normalized name: netarsudil ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Netarsudil ophthalmic solution 0.02% QD (PM)
Trial: 30862500
Drug: Timolol ophthalmic
RxNorm normalized name: timolol ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timolol ophthalmic solution 0.5% BID
Trial: 23552589
Drug: Dexmedetomidine 1ug/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 1ug/kg administered intravenously over 10 minutes before intubation (group D)
Trial: 23552589
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline administered (group C)
Trial: 12705062
Drug: Celecoxib (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (200 mg daily)
Trial: 15579735
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg octreotide long-acting repeatable (LAR) every 4 wk for 16 wk
Trial: 15579735
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg octreotide LAR
Trial: 11463593
Drug: Low tidal
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low tidal volume (VT) mechanical ventilation strategy (6 ml/kg)
Trial: 2853047
Drug: Rice bran
RxNorm normalized name: Rice bran
DrugBank: Rice bran (DB14361)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rice bran (17.1 g/d)
Trial: 2853047
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran (15.0 g/d)
Trial: 29389474
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg rosemary twice daily for one month
Trial: 23025690
Drug: Intranasal oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal oxytocin (24 IU/dose, given twice daily for 3 days)
Trial: 8625660
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (bud), 1,600 micrograms/d
Trial: 8625660
Drug: Inhaled budesonide,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide, 1,600 micrograms/d, plus oral prednisolone, 5 micrograms/d (bud + pred)
Trial: 1428609
Drug: HTR polymer
RxNorm normalized name: dicresulene polymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HTR polymer implant
Trial: 1428609
Drug: Control site
RxNorm normalized name: SOLO SITE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control site (surgically debrided without implant)
Trial: 6307772
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg ranitidine twice daily
Trial: 1853146
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg ranitidine twice daily
Trial: 19944452
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with paclitaxel and carboplatin
Trial: 28770631
Drug: Dose-matched science
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dose-matched science and technology female leadership curriculum
Trial: 26603297
Drug: Carboplatin (CBDCA,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboplatin (CBDCA, area under the curve = 5) plus pemetrexed (PEM, 500 mg/m²) followed by maintenance pemetrexed (PEM)
Trial: 20633419
Drug: DTMS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTMS treatment
Trial: 14766684
Drug: 300 mL
RxNorm normalized name: HYQVIA 30 GM / 300 ML Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mL clear liquid two hours before surgery
Trial: 9692616
Drug: Erythropoietin (Epo)
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin (Epo) therapy for 8 months
Trial: 9692616
Drug: Ketanserin treatment
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin treatment for 14 days
Trial: 11772800
Drug: Rofecoxib 50
RxNorm normalized name: rofecoxib 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 50 mg before surgery
Trial: 11772800
Drug: Rofecoxib 50
RxNorm normalized name: rofecoxib 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 50 mg after surgery
Trial: 28074750
Drug: Consultant pharmacist
RxNorm normalized name: constant albicans extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Consultant pharmacist services with academic detailing, medication monitoring system alerts, and structured recommendations for ADE management
Trial: 24742498
Drug: FDC AZI/AML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC AZI/AML 20/5 mg
Trial: 24742498
Drug: FDC AZI/AML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDC AZI/AML 20/2.5 mg
Trial: 24742498
Drug: AZI 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZI 20 mg
Trial: 24742498
Drug: AML 5
RxNorm normalized name: AML-2-23
DrugBank: AML-2-23 (DB17433)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AML 5 mg
Trial: 24742498
Drug: AML 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AML 2.5 mg
Trial: 19580461
Drug: 0.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg/kg per week of risedronate
Trial: 19580461
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg per week of risedronate
Trial: 19580461
Drug: 2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg/kg per week of risedronate
Trial: 19580461
Drug: risedronate (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: risedronate (all doses)
Trial: 19580461
Drug: 1 or
RxNorm normalized name: G-1 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 or 2 mg/kg per week of risedronate
Trial: 19091088
Drug: modified Constraint-Induced
FDA approved: no
EMA approved: no
PMDA approved: no
Description: modified Constraint-Induced Movement Therapy (modified CIMT) for 3 weeks
Trial: 15777325
Drug: Progressively loaded
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Progressively loaded implants
Trial: 12501878
Drug: Cefditoren 200
RxNorm normalized name: cefditoren 200 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefditoren 200 mg BID
Trial: 12501878
Drug: Cefditoren 400
RxNorm normalized name: cefditoren 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefditoren 400 mg BID
Trial: 12501879
Drug: Amoxicillin/clavulanate 875/125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate 875/125 mg BID
Trial: 8551535
Drug: Amoxicillin/clavulanate and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate and Lactobacillus acidophilus
Trial: 8551535
Drug: Amoxicillin/clavulanate only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate only
Trial: 27250120
Drug: DHA emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA emulsion (60 mg/kg/day)
Trial: 21927836
Drug: LCE 125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCE 125 mg after LCE 150 mg
Trial: 21927836
Drug: LCE 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LCE 100 mg
Trial: 17452165
Drug: EOB and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EOB and VE/VCO2 slope combination
Trial: 12568481
Drug: Immediate therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate therapy
Trial: 9524826
Drug: Sulbactam/cefoperazone (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulbactam/cefoperazone (2 g/4 g every 12 hours)
Trial: 9524826
Drug: Imipenem (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipenem (500 mg every 6 hours)
Trial: 2504834
Drug: Roxithromycin (RU)
RxNorm normalized name: roxithromycin
DrugBank: Roxithromycin (DB00778)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxithromycin (RU) at a daily dosage of 300 mg
Trial: 2504834
Drug: Josamycin (JM)
RxNorm normalized name: josamycin
DrugBank: Josamycin (DB01321)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Josamycin (JM) at a daily dosage of 1200 mg
Trial: 1060748
Drug: Placebo (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (no specific agent mentioned)
Trial: 17849380
Drug: Preoperative radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative radiation therapy with postoperative anastomotic leakage
Trial: 12828501
Drug: Zolmitriptan nasal
RxNorm normalized name: Zolmitriptan Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan nasal spray 5.0 mg
Trial: 12412823
Drug: Zolmitriptan nasal
RxNorm normalized name: Zolmitriptan Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan nasal spray 2.5 mg
Trial: 12828501
Drug: Zolmitriptan nasal
RxNorm normalized name: Zolmitriptan Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan nasal spray 1.0 mg
Trial: 12412823
Drug: Zolmitriptan nasal
RxNorm normalized name: Zolmitriptan Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan nasal spray 0.5 mg
Trial: 8508996
Drug: Nilvadipine 8
RxNorm normalized name: nilvadipine 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nilvadipine 8 or 16 mg once daily
Trial: 3521557
Drug: Topical carbonic
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical carbonic anhydrase inhibitor (aminozolamide) - 50 microL gel application
Trial: 25341478
Drug: ARB-H (losartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ARB-H (losartan 50 mg and hydrochlorothiazide 12.5 mg)
Trial: 25341478
Drug: Control (amlodipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (amlodipine 2.5 mg daily)
Trial: 25341478
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (including amlodipine 2.5 mg daily)
Trial: 19528204
Drug: Rosiglitazone (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (12 weeks treatment)
Trial: 17289483
Drug: Dexamethasone (DEX)
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Dexamethasone (DEX) 0.6 mg/kg
Trial: 1450496
Drug: Heparin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin alone (group A)
Trial: 6541387
Drug: Phenylpropanolamine (PPA)
DrugBank: Phenylpropanolamine (DB00397)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenylpropanolamine (PPA) 50 mg p.o. twice daily
Trial: 6541387
Drug: Estriol vaginal
RxNorm normalized name: estriol Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estriol vaginal suppositories 1 mg daily
Trial: 6541387
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with PPA and estriol
Trial: 3781985
Drug: Adenosine infusion
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adenosine infusion (70-80 micrograms X kg‐1 X min‐1)
Trial: 2188763
Drug: Control saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control saline infusion
Trial: 23983593
Drug: 0.5 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 µg/kg dexmedetomidine
Trial: 23983593
Drug: 0.75 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 µg/kg dexmedetomidine
Trial: 23983593
Drug: 1.0 µg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 µg/kg dexmedetomidine
Trial: 29668397
Drug: LED treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LED treatment
Trial: 11093999
Drug: bupivacaine 10
RxNorm normalized name: BUPivacaine 100 mg parenteral implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 10 mg + fentanyl 25 microg
Trial: 11093999
Drug: bupivacaine 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 7.5 mg + fentanyl 25 microg
Trial: 11093999
Drug: bupivacaine 5
RxNorm normalized name: Sure-Amp BUPivacaine 5 MG/ML Injectable Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 5 mg + fentanyl 25 microg
Trial: 2859924
Drug: low-dose chlorozotocin
RxNorm normalized name: chlorozotocin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: low-dose chlorozotocin (120 mg/m2)
Trial: 2859924
Drug: high-dose chlorozotocin
RxNorm normalized name: chlorozotocin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: high-dose chlorozotocin (175 mg/m2)
Trial: 27569824
Drug: L-carnitine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (3 g/L)
Trial: 27569824
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no L-carnitine)
Trial: 23519822
Drug: Rehmannia glutinosa
RxNorm normalized name: Rehmannia Glutinosa Root
DrugBank: Rehmannia glutinosa root (DB14290)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehmannia glutinosa acteosides (two 200‐mg capsules, bid) and irbesartan (one 150‐mg tablet, qd)
Trial: 23519822
Drug: Irbesartan (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan (one 150‐mg tablet, qd)
Trial: 7520395
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment and control groups
Trial: 20386016
Drug: RO5068760 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RO5068760 50 mg
Trial: 20386016
Drug: RO5068760 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RO5068760 100 mg
Trial: 20386016
Drug: RO5068760 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RO5068760 200 mg
Trial: 20386016
Drug: RO5068760 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RO5068760 400 mg
Trial: 20386016
Drug: RO5068760 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RO5068760 600 mg
Trial: 20386016
Drug: RO5068760 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RO5068760 800 mg
Trial: 20386016
Drug: RO5068760 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RO5068760 (all doses)
Trial: 12897739
Drug: Efalizumab (0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Efalizumab (0.7 mg/kg conditioning dose followed by 7 weekly doses of 2.0 mg/kg)
Trial: 11391843
Drug: Interferon alfa-2a
RxNorm normalized name: Interferon Alfa-2A
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2a monotherapy at a maintenance dose of 9 MIU daily for 12 months
Trial: 11391843
Drug: Interferon alfa-2a
RxNorm normalized name: Interferon Alfa-2A
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2a monotherapy
Trial: 8855830
Drug: Benfluorex (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benfluorex (150 mg/tablet)
Trial: 2210587
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 tablets/day)
Trial: 1516390
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml of 2.5 percent cocaine by intratracheal injection (TI) (n = 18)
Trial: 1516390
Drug: Bronchoscopic injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchoscopic injection of cocaine (BI) (n = 19)
Trial: 1516390
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml of 4 percent lidocaine delivered by nebulizer (NEB) (n = 16)
Trial: 6231942
Drug: Topical clindamycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical clindamycin phosphate (1% solution) twice daily
Trial: 6231942
Drug: Benzoyl peroxide
RxNorm normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide (5% gel) twice daily
Trial: 6231942
Drug: Benzoyl peroxide
RxNorm normalized name: Benzoyl Peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzoyl peroxide (5% gel) in the morning and clindamycin phosphate (1% solution) in the evening
Trial: 6231942
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Benzoyl peroxide and clindamycin phosphate)
Trial: 30638771
Drug: Structured personal
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured personal care (individualized multifactorial treatment)
Trial: 23153661
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of green tea extract 400 mg containing 94% pure EGCG
Trial: 19414584
Drug: Clarithromycin 500
RxNorm normalized name: clarithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 500 mg twice a day (b.i.d.) for seven doses
Trial: 19414584
Drug: Clarithromycin 1000
RxNorm normalized name: clarithromycin 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin 1000 mg twice a day (b.i.d.)
Trial: 14711556
Drug: Raloxifene (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Raloxifene (180 mg/d)
Trial: 11907847
Drug: Betamethasone valerate
RxNorm normalized name: Betamethasone Valerate
DrugBank: Betamethasone (DB00443)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone valerate foam (Luxiq) twice a day for four weeks
Trial: 9134274
Drug: Imidapril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidapril (5 mg daily)
Trial: 7701055
Drug: Oxazepam (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam (40 mg)
Trial: 16182353
Drug: Oxazepam (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxazepam (20 mg)
Trial: 29986448
Drug: Shooters with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shooters with BLL ≥ 5 µg/dL
Trial: 29986448
Drug: Shooters with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shooters with BLL ≥ 10 µg/dL